GAMBATO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.968
EU - Europa 381
AS - Asia 315
SA - Sud America 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.963
CN - Cina 243
IT - Italia 124
FI - Finlandia 66
DE - Germania 65
SE - Svezia 57
VN - Vietnam 53
GB - Regno Unito 35
IN - India 13
FR - Francia 7
IE - Irlanda 7
UA - Ucraina 7
CA - Canada 4
BR - Brasile 3
ES - Italia 3
NL - Olanda 3
AT - Austria 2
ET - Etiopia 2
PL - Polonia 2
SG - Singapore 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
BZ - Belize 1
EC - Ecuador 1
JP - Giappone 1
RO - Romania 1
SI - Slovenia 1
Totale 3.672
Salva come PNG Salva come JPEG
Città #
Fairfield 509
Chandler 307
Ann Arbor 300
Woodbridge 245
Ashburn 225
Houston 216
Cambridge 184
Seattle 178
Wilmington 131
San Diego 77
Beijing 75
Des Moines 67
Medford 57
Princeton 57
Dong Ket 53
Padova 44
Helsinki 42
Roxbury 37
Nanjing 27
Guangzhou 24
Shenyang 15
Boardman 14
London 12
Hebei 10
Falls Church 9
New York 9
Munich 8
Ogden 8
Pune 8
Dublin 7
Cagliari 6
Hefei 6
Milan 6
Tianjin 6
Changsha 5
Fuzhou 5
Jinan 5
Nanchang 5
Ningbo 5
Paris 5
Trieste 5
Vicenza 5
Washington 5
Zhengzhou 5
Chicago 4
Phoenix 4
Redwood City 4
Borås 3
Chiswick 3
Dolo 3
Kharkiv 3
Kunming 3
Lappeenranta 3
Lozzo Atestino 3
Nürnberg 3
Recife 3
Shanghai 3
Addis Ababa 2
Amsterdam 2
Boston 2
Fremont 2
Hounslow 2
Kilburn 2
Majadahonda 2
Prescot 2
Quzhou 2
Rockville 2
Singapore 2
Taipei 2
Taizhou 2
Venice 2
Aachen 1
Belize City 1
Biassono 1
Brussels 1
Bussolengo 1
Calgary 1
Campolongo 1
Charles Town 1
Charlotte 1
Chongqing 1
Columbus 1
Council Bluffs 1
Dearborn 1
Dubai 1
Enschede 1
Essen 1
Esslingen am Neckar 1
Falkenstein 1
Ferentino 1
Foggia 1
Fontaniva 1
Granada 1
Guiyang 1
Haikou 1
Hangzhou 1
Hunedoara 1
Jiaxing 1
Las Vegas 1
Laurel 1
Totale 3.128
Salva come PNG Salva come JPEG
Nome #
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 141
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 135
Meld-na and Survival Benefit In Liver Transplantation 111
Liver Transplantation In Cirrhotic Patients With Meld Score < 18: A New Prognostic Model To Predict Drop-out From the Waiting List 108
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 107
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 105
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 100
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 100
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 99
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 99
Model for End-Stage Liver Disease-Sodium and Survival Benefit in Liver Transplantation. 96
De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2008 95
Female gender in the setting of liver transplantation. 93
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 87
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 85
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 84
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 82
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 81
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis 77
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study. 77
A New Allocation Model For Liver Transplantation Combining Urgency Based Prioritization With Donor-recipient Matching: A Prospective Controlled Study 76
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 76
Prioritization Tools To Predict Short and Long Term Mortality Following Liver Transplantation 75
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 74
Liver transplantation for viral hepatitis in 2015 74
Estimation of the Harm To the Waiting List As Crucial Factor In the Selection of Patients With Hepatocellular Carcinoma For Liver Transplantation 72
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? 67
A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection 63
Extending transplantation criteria for hepatocellular carcinoma 60
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation 60
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 58
Italian practical clinical guidelines on cholangiocarcinoma: Part II, Treatment 58
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 55
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study 53
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging 51
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 51
Incidence of De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2009 48
Prospective Evaluation of Long Term Cognitive and Neurological Alterations in Liver Transplanted Patients with Central Pontine (CPM) and Extrapontine Myelinolysis (EPM) 48
Host and virological features of HCV infection in liver transplant setting 48
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology 47
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 46
Management of portal hypertension severe complications 45
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 45
Drug induced liver injury: from pathogenesis to liver transplantation 45
Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor 39
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 39
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 36
Impact of Donor-Recipient Risk Factors on Patient and Graft Survival after Liver Transplantation? A Single Centre Experience 35
Reply 35
Malnourished cirrhotic patient: what should we do? 30
Impact of Recipient MELD and Na plus , Donor Age on Short Patient Survival Following Liver Transplantation 24
New indications for liver transplantation 21
Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy 21
Invasive fungal infection before and after liver transplantation 19
Management of hepatocellular carcinoma recurrence after liver transplantation 18
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 17
Recent advances in the management of acute variceal hemorrhage 16
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 15
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 8
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 6
Chest X-ray Interpretation: Detecting Devices and Device-Related Complications 5
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 3
Trends in liver transplantation for primary sclerosing cholangitis 3
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role? 2
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 1
Totale 3.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.818
article - articoli 15.597
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019219 0 0 0 0 0 0 0 0 0 0 105 114
2019/2020656 82 29 21 60 61 47 71 68 69 70 61 17
2020/2021559 32 31 38 30 35 14 29 43 77 95 41 94
2021/2022877 46 107 62 36 41 118 78 50 37 52 79 171
2022/2023613 103 72 20 76 100 81 12 39 56 3 45 6
2023/2024383 30 68 45 34 36 46 55 26 20 23 0 0
Totale 3.750